Publication | Closed Access
On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain
158
Citations
22
References
2000
Year
Absolute ConcentrationsClinical NeurologyVivo ExaminationsSocial SciencesMagnetic Resonance ImagingBrain InjuryNeurologyClinical ChemistryNeuropathologyLaboratory MedicineRadiologyNeuroimaging ModalityNeuropharmacologyNeuroimagingCerebral Blood FlowBrain ImagingPharmacologyNeuroimaging BiomarkersNeurophysiologyMagnetic Resonance SpectroscopyNeuroscienceElectrophysiologyInstitutional UnitsMedicine
The reliability of a single-voxel, localized proton magnetic resonance spectroscopy protocol suitable for clinical studies was investigated by means of in vitro, single-subject in vivo and multi-subject in vivo examinations of healthy adults aged from 19 to 67 years. The study was performed at 1.5 T using a standard quadrature head coil and a single voxel PRESS sequence (in vitro TR/TE = 1500/30 ms, in vivo TR/TE=2000/35 ms). Eighty-four in vitro and 30 single-subject examinations were statistically evaluated after quantification, including the calculation of the coefficients of variations (CV) for choline (Cho), creatine (Cr), myo-inositol (mI), lactate (Lac), N-acetyl-aspartate (NAA) and unresolved glutamine, glutamate and GABA (Glx). The CVs for absolute concentrations of the main metabolites Cho, Cr and NAA, ranged from 3.3% (3.8) to 4.0% (6.4%) (the in vivo results are given in brackets). Multi-subject CVs of absolute concentrations for Cho, Cr and NAA ranged from 7.6% to 15.0%. CVs of relative in vivo concentrations were found to be higher than CVs of absolute concentrations. Due to the better reproducibility of intra-individual absolute in vivo concentrations, cross-over studies using institutional units are recommended.
| Year | Citations | |
|---|---|---|
Page 1
Page 1